Pharmaceuticals

SNP Genotyping And Analysis Industry Growth Insights: Revenue Forecast to 2030

February 18, 2026February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the snp genotyping and analysis market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the SNP Genotyping And Analysis Market from 2026 to 2030?

The snp genotyping and analysis market has experienced significant expansion in recent years. It is projected to increase from $18.5 billion in 2025 to $22.24 billion in 2026, reflecting a compound annual growth rate (CAGR) of 20.2%. This historical growth can be linked to factors like the decreasing cost of genetic testing, the broadening scope of academic genomics research, advancements in disease diagnostics, increased pharmaceutical R&D investment, and the evolution of microarray technologies.

The snp genotyping and analysis market size is anticipated to undergo substantial growth in the coming years, with projections indicating it will attain a value of $46.29 billion by 2030, driven by a compound annual growth rate (CAGR) of 20.1%. The expansion throughout this forecast period is attributable to factors such as the development of personalized medicine, increased application of companion diagnostics, AI-powered genomic analytics, the broadening scope of clinical genomics, and various governmental genomics programs. Key trends expected during this period include the wider adoption of precision medicine applications, the rising acceptance of pharmacogenomics, enhanced utilization of cfdna and liquid biopsy, the proliferation of high-throughput genotyping platforms, and the integration of AI into genetic data analysis.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24402&type=smp

What Drivers Are Affecting Demand In The SNP Genotyping And Analysis Market?

The increasing prevalence of genetic diseases is projected to fuel the expansion of the SNP genotyping and analysis market. These conditions are disorders caused by abnormalities in an individual’s DNA, which can be inherited from one or both parents or arise from mutations during cell division. The rising impact of genetic diseases stems from enhanced public awareness and improved diagnostic technologies, leading to more diagnoses and a greater understanding of these disorders. SNP genotyping and analysis aid in addressing genetic diseases by identifying genetic variations linked to disease risk, progression, and drug response, thereby enabling early diagnosis and personalized treatment. For instance, in February 2023, the World Health Organization, a Switzerland based international public health agency, reported that congenital disorders were estimated to cause approximately 240,000 newborn deaths worldwide within the first 28 days of life each year, alongside an additional 170,000 deaths among children aged 1 month to 5 years. Consequently, the growing burden of genetic diseases is driving the growth of the SNP genotyping and analysis market.

Which Segment Groups Are Influencing The SNP Genotyping And Analysis Market?

The snp genotyping and analysis market covered in this report is segmented –

1) By Sample Type: Genomic DNA, Ribonucleic Acid (RNA), Cell-Free DNA (cfDNA), Plasma Samples, Whole Blood

2) By Technology: Microarrays And GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex, Sequemon MassArray Maldi-TOF, Other Technologies

3) By Application: Disease Diagnostics, Pharmacogenomics, Precision Medicine, Forensic Science, Agriculture And Livestock

4) By End User: Hospitals And Clinics, Research Laboratories, Pharmaceutical And Biotechnological Companies, Diagnostic Laboratories, Academic And Government Institutions

Subsegments:

1) By Genomic DNA: Whole Genome Sequencing (WGS), Targeted Sequencing, Microarrays

2) By Ribonucleic Acid (RNA): RNA-Seq, Expression Profiling, Microarrays

3) By Cell-Free DNA (cfDNA): Liquid Biopsy, Non-Invasive Prenatal Testing (NIPT), Oncology Research

4) By Plasma Samples: Circulating Tumor DNA (ctDNA), Liquid Biopsy Applications, Diagnostics

5) By Whole Blood: DNA Extraction And Analysis, Blood-Based Genomic Studies, Genotyping And Molecular Diagnostics

Which Trends Are Influencing The Performance And Direction Of The SNP Genotyping And Analysis Market?

Companies prominent in the SNP genotyping and analysis market are concentrating on creating sophisticated technological solutions, such as agricultural large-scale low-pass whole genome sequencing, to tackle significant issues in the molecular breeding genotyping of agricultural diploid species. Agricultural whole genome sequencing involves deciphering the full genetic makeup of plants or animals with the aim of enhancing characteristics such as productivity, resilience to diseases, and adaptation to various environments. For instance, in June 2024, MGI Tech, a China-based biotechnology company, introduced an exceptionally effective end-to-end workflow system for agricultural large-scale low-pass whole genome sequencing (low-pass WGS). This system comprises an automated comprehensive product suite encompassing DNA extraction, library preparation, sequencing, and the identification of SNPs and InDels, tailored expressly for molecular breeding genotyping in agricultural diploid species. It incorporates sophisticated automation platforms and utilizes MGI’s DNBSEQ-T7 and DNBSEQ-G400 sequencers, enabling exceptional throughput and adaptability. Furthermore, the workflow integrates pig reference panels and data analysis software, simplifying genotyping by eliminating the need for personalized database development.

Who Are The Top-Performing Companies In The SNP Genotyping And Analysis Market In Recent Years?

Major companies operating in the snp genotyping and analysis market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Eurofins Genomics Inc., Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Life Sciences Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., Azenta Life Sciences Inc., LGC Limited, Invitae Corporation, Oxford Nanopore Technologies Limited, Standard BioTools Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Sophia Genetics SA, Genedata AG, Genotypic Technology Private Limited, PREMIER Biosoft International

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/snp-genotyping-and-analysis-global-market-report

Which Region Currently Holds The Largest Share Of The SNP Genotyping And Analysis Market?

North America was the largest region in the SNP genotyping and analysis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the snp genotyping and analysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized SNP Genotyping And Analysis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24402&type=smp

Browse Through More Reports Similar to the Global SNP Genotyping And Analysis Market 2026, By The Business Research Company

Single Nucleotide Polymorphism Snp Genotyping Market Report 2026

https://www.thebusinessresearchcompany.com/report/single-nucleotide-polymorphism-snp-genotyping-global-market-report

Genotyping Market Report 2026

https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report

Genotyping Assay Market Report 2026

https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795